Scientists leverage ultrasound to build new blood vessels in living tissue
A technology most often used for medical imaging is being repurposed to treat damaged tissue in a range of applications.
How the brain interprets motion while in motion
New findings about how the brain interprets sensory information may have applications for treating brain disorders and designing artificial intelligence.
Connecting the dots between aging, Alzheimer’s, and ‘junk DNA’
Biologists Vera Gorbunova and Andrei Seluanov join colleagues at Brown and NYU in the quest to find potential targets of treatments and therapeutics for neurodegenerative diseases.
Grant helps biologist study ‘complex interplay’ of nature and nurture on genes
Jennifer Brisson, an associate professor of biology, will further her study of phenotypic plasticity, which describes how an organism’s development is influenced by its environment, with a five-year, $2 million NIH grant.
Six Rochester graduate students offered National Institutes of Health fellowship grants
Five graduate students from the University of Rochester Medical Center and one from the School of Arts and Sciences have been offered National Institutes of Health F31 fellowship grants to support their health-related research.
Director of National Institutes of Health visits Medical Center
Francis Collins met with graduate students and junior researchers to discuss the importance of communicating science to the public and policymakers, and increasing diversity in biomedical research.
Researcher receives $1.25M grant to unlock ‘magic’ behind babies, language
Elika Bergelson, a newly-appointed research assistant professor in the Department of Brain and Cognitive Sciences, focuses on understanding how babies learn words between 6-to 18-months old. Funding from the NIH recognizes Bergelson as one of the nation’s “exceptional early career scientist” and will help her pathbreaking work advance more quickly.
Medical Center joins NIH network to fight arthritis, lupus
The National Institutes of Health has invited the Medical Center to join the NIH Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network. Made up of 11 research groups from around the country, its aim is to develop new treatments for patients with the conditions.